BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

Clinical trial NCT07485049 · RECRUITING

Trial details

NCT number: NCT07485049
Sponsor: Nader Sanai
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Glioblastoma (GBM)

Start date: 2026-05-07
Primary completion: 2027-11-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.